trending Market Intelligence /marketintelligence/en/news-insights/trending/hM3d4PNOb_xy9iXpp9z9Ug2 content esgSubNav
In This List

Vericel prices $17M common stock offering

Case Study

Identifying PPE Suppliers During the Pandemic


Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Vericel prices $17M common stock offering

Vericel Corp. priced an underwritten public offering of 6.2 million common shares at $2.75 apiece.

The company granted underwriters an overallotment option to buy up to an additional 930,000 shares.

Gross proceeds from the offering are expected to total about $17 million, before deducting the underwriting discount and other estimated offering expenses.

Vericel expects to use the proceeds to support the commercialization of MACI, expand promotional efforts for Epicel, expand and optimize manufacturing and for other general corporate purposes.

The offering is expected to close Dec. 21, subject to customary closing conditions.

Piper Jaffray & Co. is acting as the sole manager for the offering.